These include modulation of the microvasculature via angiogenesis-targeted ... on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors ...

Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation ...

Tumor cells transform fibroblasts into cancer-associated fibroblasts, which have an important immunosuppressive activity on which ... The focus is on early tumor growth prior to angiogenesis and the ...

Studies have shown that interferon-responsive macrophages have an immunosuppressive ... biological processes required for tumor survival and development (including glucose metabolism, cell ...

In tumor microenvironments, substances like 8-OHG drive macrophage polarization towards the immunosuppressive M2 type. M1 macrophages, with higher ferritin expression, are more resistant to ...

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.